Bedside drug production will truly enable personalized medicine
Bedside development of biopharmaceuticals, which bypasses the pharmaceutical industry, makes personalized medicine scientifically and economically possible.
by Huub Schellekens
Jun 19, 2017
4 minutes
Making medicines tailored to the needs and characteristics of individual patients is the dream for many scientists. This kind of personalized medicine approach would provide treatment with the highest possible effectiveness and safety, and would also save money. But it requires rethinking how we make medications.
The starting point of personalized medicine can be traced to the completion of the Human Genome Project, which sequenced almost the entire human genome, in 2001. Since then, however, only a limited number of personalized pharmaceutical treatments have reached patients. Technical issues like the lack of validated genetic tests and biomarkers to predict
You’re reading a preview, subscribe to read more.
Start your free 30 days